NASDAQ:BKYI

BIO-key International Competitors

$3.35
-0.05 (-1.47 %)
(As of 05/10/2021 11:08 AM ET)
Add
Compare
Today's Range
$3.35
$3.41
50-Day Range
$3.09
$4.22
52-Week Range
$2.75
$13.68
Volume889 shs
Average Volume440,426 shs
Market Capitalization$26.19 million
P/E RatioN/A
Dividend YieldN/A
Beta1.02

Competitors

BIO-key International (NASDAQ:BKYI) Vs. CSCO, IBM, HPQ, ANET, FFIV, and JNPR

Should you be buying BKYI stock or one of its competitors? Companies in the industry of "computer & office equipment" are considered alternatives and competitors to BIO-key International, including Cisco Systems (CSCO), International Business Machines (IBM), HP (HPQ), Arista Networks (ANET), F5 Networks (FFIV), and Juniper Networks (JNPR).

Cisco Systems (NASDAQ:CSCO) and BIO-key International (NASDAQ:BKYI) are both computer and technology companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, risk, earnings, profitability, dividends, valuation and institutional ownership.

Analyst Ratings

This is a summary of current recommendations for Cisco Systems and BIO-key International, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Cisco Systems0131102.46
BIO-key International00103.00

Cisco Systems currently has a consensus target price of $50.7391, suggesting a potential downside of 5.62%. BIO-key International has a consensus target price of $6.00, suggesting a potential upside of 79.10%. Given BIO-key International's stronger consensus rating and higher possible upside, analysts plainly believe BIO-key International is more favorable than Cisco Systems.

Profitability

This table compares Cisco Systems and BIO-key International's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Cisco Systems21.76%32.64%12.94%
BIO-key International-770.75%-379.14%-201.75%

Earnings and Valuation

This table compares Cisco Systems and BIO-key International's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cisco Systems$49.30 billion4.60$11.21 billion$2.9218.41
BIO-key International$2.27 million11.54$-14,590,000.00N/AN/A

Cisco Systems has higher revenue and earnings than BIO-key International.

Institutional & Insider Ownership

70.6% of Cisco Systems shares are owned by institutional investors. Comparatively, 29.2% of BIO-key International shares are owned by institutional investors. 0.0% of Cisco Systems shares are owned by company insiders. Comparatively, 8.8% of BIO-key International shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Risk and Volatility

Cisco Systems has a beta of 0.95, meaning that its share price is 5% less volatile than the S&P 500. Comparatively, BIO-key International has a beta of 1.02, meaning that its share price is 2% more volatile than the S&P 500.

Summary

Cisco Systems beats BIO-key International on 8 of the 13 factors compared between the two stocks.

International Business Machines (NYSE:IBM) and BIO-key International (NASDAQ:BKYI) are both computer and technology companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, profitability, dividends, valuation, analyst recommendations, risk and earnings.

Volatility and Risk

International Business Machines has a beta of 1.25, suggesting that its stock price is 25% more volatile than the S&P 500. Comparatively, BIO-key International has a beta of 1.02, suggesting that its stock price is 2% more volatile than the S&P 500.

Profitability

This table compares International Business Machines and BIO-key International's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
International Business Machines10.53%48.69%6.59%
BIO-key International-770.75%-379.14%-201.75%

Institutional and Insider Ownership

55.7% of International Business Machines shares are owned by institutional investors. Comparatively, 29.2% of BIO-key International shares are owned by institutional investors. 0.2% of International Business Machines shares are owned by company insiders. Comparatively, 8.8% of BIO-key International shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Analyst Ratings

This is a breakdown of current recommendations and price targets for International Business Machines and BIO-key International, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
International Business Machines06402.40
BIO-key International00103.00

International Business Machines presently has a consensus target price of $148.4444, indicating a potential upside of 0.48%. BIO-key International has a consensus target price of $6.00, indicating a potential upside of 79.10%. Given BIO-key International's stronger consensus rating and higher possible upside, analysts plainly believe BIO-key International is more favorable than International Business Machines.

Earnings & Valuation

This table compares International Business Machines and BIO-key International's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
International Business Machines$77.15 billion1.71$9.43 billion$12.8111.52
BIO-key International$2.27 million11.54$-14,590,000.00N/AN/A

International Business Machines has higher revenue and earnings than BIO-key International.

Summary

International Business Machines beats BIO-key International on 9 of the 13 factors compared between the two stocks.

BIO-key International (NASDAQ:BKYI) and HP (NYSE:HPQ) are both computer and technology companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, earnings, dividends, profitability, analyst recommendations, valuation and risk.

Analyst Ratings

This is a summary of current recommendations for BIO-key International and HP, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
BIO-key International00103.00
HP25602.31

BIO-key International presently has a consensus target price of $6.00, suggesting a potential upside of 79.10%. HP has a consensus target price of $24.4643, suggesting a potential downside of 31.43%. Given BIO-key International's stronger consensus rating and higher possible upside, research analysts plainly believe BIO-key International is more favorable than HP.

Volatility & Risk

BIO-key International has a beta of 1.02, suggesting that its share price is 2% more volatile than the S&P 500. Comparatively, HP has a beta of 1.08, suggesting that its share price is 8% more volatile than the S&P 500.

Profitability

This table compares BIO-key International and HP's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
BIO-key International-770.75%-379.14%-201.75%
HP5.02%-196.27%9.63%

Valuation & Earnings

This table compares BIO-key International and HP's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BIO-key International$2.27 million11.54$-14,590,000.00N/AN/A
HP$56.64 billion0.79$2.84 billion$2.2815.65

HP has higher revenue and earnings than BIO-key International.

Institutional and Insider Ownership

29.2% of BIO-key International shares are owned by institutional investors. Comparatively, 80.6% of HP shares are owned by institutional investors. 8.8% of BIO-key International shares are owned by insiders. Comparatively, 0.3% of HP shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

HP beats BIO-key International on 9 of the 13 factors compared between the two stocks.

BIO-key International (NASDAQ:BKYI) and Arista Networks (NYSE:ANET) are both computer and technology companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, valuation, institutional ownership, analyst recommendations, profitability, dividends and earnings.

Volatility and Risk

BIO-key International has a beta of 1.02, indicating that its stock price is 2% more volatile than the S&P 500. Comparatively, Arista Networks has a beta of 1.21, indicating that its stock price is 21% more volatile than the S&P 500.

Analyst Recommendations

This is a summary of current ratings and recommmendations for BIO-key International and Arista Networks, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
BIO-key International00103.00
Arista Networks071302.65

BIO-key International presently has a consensus target price of $6.00, suggesting a potential upside of 79.10%. Arista Networks has a consensus target price of $338.5263, suggesting a potential upside of 2.19%. Given BIO-key International's stronger consensus rating and higher probable upside, equities analysts plainly believe BIO-key International is more favorable than Arista Networks.

Profitability

This table compares BIO-key International and Arista Networks' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
BIO-key International-770.75%-379.14%-201.75%
Arista Networks32.06%20.37%14.19%

Valuation and Earnings

This table compares BIO-key International and Arista Networks' top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BIO-key International$2.27 million11.54$-14,590,000.00N/AN/A
Arista Networks$2.41 billion10.48$859.87 million$8.6938.12

Arista Networks has higher revenue and earnings than BIO-key International.

Institutional and Insider Ownership

29.2% of BIO-key International shares are held by institutional investors. Comparatively, 61.8% of Arista Networks shares are held by institutional investors. 8.8% of BIO-key International shares are held by insiders. Comparatively, 23.8% of Arista Networks shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

Arista Networks beats BIO-key International on 10 of the 13 factors compared between the two stocks.

F5 Networks (NASDAQ:FFIV) and BIO-key International (NASDAQ:BKYI) are both computer and technology companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, earnings, risk, valuation, institutional ownership and profitability.

Profitability

This table compares F5 Networks and BIO-key International's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
F5 Networks13.08%19.72%9.33%
BIO-key International-770.75%-379.14%-201.75%

Volatility & Risk

F5 Networks has a beta of 1.13, meaning that its stock price is 13% more volatile than the S&P 500. Comparatively, BIO-key International has a beta of 1.02, meaning that its stock price is 2% more volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for F5 Networks and BIO-key International, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
F5 Networks04902.69
BIO-key International00103.00

F5 Networks currently has a consensus price target of $203.8571, indicating a potential upside of 10.75%. BIO-key International has a consensus price target of $6.00, indicating a potential upside of 79.10%. Given BIO-key International's stronger consensus rating and higher probable upside, analysts clearly believe BIO-key International is more favorable than F5 Networks.

Insider & Institutional Ownership

90.7% of F5 Networks shares are held by institutional investors. Comparatively, 29.2% of BIO-key International shares are held by institutional investors. 0.3% of F5 Networks shares are held by insiders. Comparatively, 8.8% of BIO-key International shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Earnings & Valuation

This table compares F5 Networks and BIO-key International's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
F5 Networks$2.35 billion4.83$307.44 million$6.6627.64
BIO-key International$2.27 million11.54$-14,590,000.00N/AN/A

F5 Networks has higher revenue and earnings than BIO-key International.

Summary

F5 Networks beats BIO-key International on 9 of the 13 factors compared between the two stocks.

Juniper Networks (NYSE:JNPR) and BIO-key International (NASDAQ:BKYI) are both computer and technology companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, profitability, analyst recommendations, valuation, institutional ownership, risk and dividends.

Profitability

This table compares Juniper Networks and BIO-key International's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Juniper Networks8.92%8.30%4.29%
BIO-key International-770.75%-379.14%-201.75%

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Juniper Networks and BIO-key International, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Juniper Networks22302.14
BIO-key International00103.00

Juniper Networks currently has a consensus target price of $25.50, indicating a potential downside of 6.59%. BIO-key International has a consensus target price of $6.00, indicating a potential upside of 79.10%. Given BIO-key International's stronger consensus rating and higher probable upside, analysts plainly believe BIO-key International is more favorable than Juniper Networks.

Valuation & Earnings

This table compares Juniper Networks and BIO-key International's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Juniper Networks$4.45 billion2.01$345 million$1.2122.56
BIO-key International$2.27 million11.54$-14,590,000.00N/AN/A

Juniper Networks has higher revenue and earnings than BIO-key International.

Insider & Institutional Ownership

89.3% of Juniper Networks shares are held by institutional investors. Comparatively, 29.2% of BIO-key International shares are held by institutional investors. 1.2% of Juniper Networks shares are held by insiders. Comparatively, 8.8% of BIO-key International shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Volatility and Risk

Juniper Networks has a beta of 0.9, indicating that its stock price is 10% less volatile than the S&P 500. Comparatively, BIO-key International has a beta of 1.02, indicating that its stock price is 2% more volatile than the S&P 500.

Summary

Juniper Networks beats BIO-key International on 8 of the 13 factors compared between the two stocks.


BIO-key International Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Cisco Systems logo
CSCO
Cisco Systems
2.4$53.76-0.6%$225.57 billion$49.30 billion21.85
International Business Machines logo
IBM
International Business Machines
2.5$147.63-1.5%$129.97 billion$77.15 billion16.72Ex-Dividend
HP logo
HPQ
HP
2.0$35.68-0.3%$44.34 billion$56.64 billion17.84
Arista Networks logo
ANET
Arista Networks
1.6$331.26-0.8%$25.06 billion$2.41 billion37.10Earnings Announcement
F5 Networks logo
FFIV
F5 Networks
1.7$184.07-0.1%$11.36 billion$2.35 billion36.67
Juniper Networks logo
JNPR
Juniper Networks
1.9$27.30-0.4%$8.91 billion$4.45 billion23.53
Extreme Networks logo
EXTR
Extreme Networks
1.5$11.00-3.8%$1.44 billion$948.02 million-13.41
A10 Networks logo
ATEN
A10 Networks
1.9$9.06-0.8%$706.08 million$212.63 million69.70
Allot Communications logo
ALLT
Allot Communications
1.6$17.73-2.1%$640.79 million$110.10 million-65.66Upcoming Earnings
Gap Down
Digi International logo
DGII
Digi International
1.6$17.90-0.2%$530.90 million$279.27 million61.73Earnings Announcement
Silicom logo
SILC
Silicom
1.6$41.29-0.9%$287.34 million$105.24 million41.29
Intrusion logo
INTZ
Intrusion
1.4$9.49-7.3%$179.32 million$13.64 million-55.82Earnings Announcement
Analyst Revision
Lantronix logo
LTRX
Lantronix
0.9$5.20-3.1%$154.87 million$59.88 million-16.25
B.O.S. Better Online Solutions logo
BOSC
B.O.S. Better Online Solutions
0.5$3.30-1.2%$17.35 million$33.82 million-8.92
This page was last updated on 5/10/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.